http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-0109515-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1aebbf969ab006c1c6b84ac97ed0120f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D221-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-473
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D221-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-706
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-473
filingDate 2001-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9562c243f07522335e1de0f12c7ba27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7dc498f4c885156d7944c73b3d245e5a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cea53d016fefd309931aa5fda8a76d8e
publicationDate 2004-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-0109515-A
titleOfInvention Apomorphine Derivatives and Methods for Their Use
abstract "APOMORPHIN DERIVATIVES AND METHODS FOR USE". Apomorphine derived compounds; pharmaceutically active compositions of apomorphine derived compounds; and the use of apomorphine-derived compounds in methods of treating sexual dysfunction or to enhance the efficacy of apomorphine for apomorphine-treated patients are described. Apomorphine derivatives may be esters, ethers, amides, mixed anhydrides, hemiacetals, glucuronates, sulfates or phosphonates. The apomorphine derivative preferably is norapomorphine.
priorityDate 2000-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6005
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415716921
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503384
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414022007
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6326969
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID30133

Total number of triples: 34.